Federated Hermes’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-110,914
| Closed | -$221K | – | 2130 |
|
|
2024
Q3 | $221K | Buy |
110,914
+60,644
| +121% | +$121K | ﹤0.01% | 1466 |
|
|
2024
Q2 | $176K | Buy |
50,270
+570
| +1% | +$2K | ﹤0.01% | 1502 |
|
|
2024
Q1 | $138K | Buy |
+49,700
| New | +$138K | ﹤0.01% | 1546 |
|
|
2023
Q1 | – | Sell |
-15
| Closed | -$38 | – | 2177 |
|
|
2022
Q4 | $38 | Buy |
+15
| New | +$38 | ﹤0.01% | 2134 |
|
|
2022
Q3 | – | Sell |
-280,100
| Closed | -$781K | – | 2182 |
|
|
2022
Q2 | $781K | Buy |
280,100
+280,098
| +14,004,900% | +$781K | ﹤0.01% | 1237 |
|
|
2022
Q1 | $1K | Buy |
+2
| New | +$1K | ﹤0.01% | 2095 |
|
|
2020
Q2 | – | Sell |
-25,462
| Closed | -$299K | – | 2290 |
|
|
2020
Q1 | $299K | Buy |
+25,462
| New | +$299K | ﹤0.01% | 1501 |
|
|
2018
Q4 | – | Sell |
-9,298
| Closed | -$294K | – | 2243 |
|
|
2018
Q3 | $294K | Sell |
9,298
-183,380
| -95% | -$5.8M | ﹤0.01% | 1556 |
|
|
2018
Q2 | $7.49M | Buy |
192,678
+100,373
| +109% | +$3.9M | 0.02% | 564 |
|
|
2018
Q1 | $2.55M | Buy |
92,305
+20,708
| +29% | +$572K | 0.01% | 865 |
|
|
2017
Q4 | $1.3M | Buy |
+71,597
| New | +$1.3M | ﹤0.01% | 1120 |
|
|
2014
Q4 | – | Sell |
-375,000
| Closed | -$3.12M | – | 1996 |
|
|
2014
Q3 | $3.12M | Hold |
375,000
| – | – | 0.01% | 802 |
|
|
2014
Q2 | $4.62M | Buy |
+375,000
| New | +$4.62M | 0.01% | 665 |
|